Results 31 to 40 of about 55,486 (297)
Background: Interferon-gamma release assay (IGRA) has been used in latent tuberculosis (TB) infection and TB diagnosis, but the results from different high TB-endemic countries are different.
Wan-Li Kang +10 more
doaj +1 more source
Performance of an interferon-γ release assay-based test for cell-mediated immunity to SARS-CoV-2
In search for immunological correlates of protection against acute coronavirus disease 2019 (COVID-19) there is a need for high through-put assays for cell-mediated immunity (CMI) to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Luís Fonseca Brito +16 more
doaj +1 more source
Predictors of interferon-gamma release assay results and their association with COVID-19 infection outcomes. [PDF]
BACKGROUND: An ‘indeterminate’ interferon-gamma release assay (IGRA) result used in the diagnosis of latent TB infection (LTBI) is most commonly due to an inadequate control (or ‘mitogen’) response, which may reflect underlying T-cell dysfunction ...
Kang SJW +3 more
europepmc +2 more sources
Interferon-gamma release assays in tuberculous uveitis: a comprehensive review
Tuberculous uveitis (TBU) comprises a broad clinical spectrum of ocular manifestations, making its diagnosis challenging. Ophthalmologists usually require evidence from investigations to confirm or support a clinical diagnosis of TBU. Since direct isolation of the causative organism from ocular specimens has limitations owing to the small volume of the
Usanee Tungsattayathitthan +4 more
openaire +3 more sources
Objective: To determine the frequency of hypovitaminosis D in patients with uveitis, and to analyse its association with gender and interferon-gamma release assay status. Method: The retrospective, cross-sectional study was conducted in September 2021
Sehrish Nizar Ali Momin +4 more
doaj +1 more source
Background. Cutaneous drug reactions are common but diagnostically challenging due to phenotypic heterogeneity and simultaneous exposure to multiple drugs. These limitations prompted the development of diagnostic tests. Aims.
Ilan Goldberg +4 more
doaj +1 more source
Positivity of interferon-gamma release assay among foreign-born individuals, Tokyo, Japan, 2015–2017
Background: The aim of this study is to analyze interferon-gamma release assay (IGRA) data of foreign-born individuals in Japan derived from tuberculosis (TB) contact investigations.
Satoshi Miyake +5 more
doaj +1 more source
Interferon-Gamma Release Assay in a Patient with Tuberculosis Verrucosa Cutis [PDF]
Dear Editor: A 62-year-old man presented with an annular plaque that had been present for 35 years on his left inner thigh. Physical examination revealed a 7×8 cm annular erythematous plaque with central clearing and hyperpigmentation (Fig. 1). We suspected tinea cruris, granuloma annulare, and erythema annulare centrifugum, and performed a 4-mm ...
Kim, Geon +4 more
openaire +2 more sources
BCG, Bacille-Calmette Guérin; CI, confidence interval; HIV, human immunodeficiency virus; IDU, injection drug users. OR, odds ratio; TB, tuberculosis*Excluding 31 subjects with indeterminate interferon-gamma release assay result.†Adjusted for age, sex ...
Hsi-Hsun Lin (473561) +11 more
core +1 more source
QuantiFERON®-TB gold in-tube performance for diagnosing active tuberculosis in children and adults in a high burden setting. [PDF]
To determine whether QuantiFERON®-TB Gold In-Tube (QFT) can contribute to the diagnosis of active tuberculosis (TB) in children in a high-burden setting and to assess the performance of QFT and tuberculin skin test (TST) in a prospective cohort of TB ...
Rose, Michala Vaaben +36 more
core +1 more source

